Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about RETINA: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | RETINA |
| Key Genes/Proteins | AMYLOID, AQP4, C1Q, CASP3, CGAS |
| Related Diseases | AGING, ALS, ALZHEIMER, ALZHEIMER'S DISEASE, APOPTOSIS |
| Related Pathways | CALCIUM SIGNALING |
graph TD
RETINA["RETINA"]
RETINA -.biomarker for.-> Alzheimer_s_Disease["Alzheimer's Disease"]
RETINA -->|"activates"| SPINAL_CORD["SPINAL CORD"]
RETINA -->|"implicated in"| T_CELLS["T CELLS"]
RETINA -->|"causes"| RETINAL_DEGENERATION["RETINAL DEGENERATION"]
RETINA -->|"activates"| STROKE["STROKE"]
AMYLOID_BETA["AMYLOID BETA"] -->|"expressed in"| RETINA
TAU_PROTEIN["TAU PROTEIN"] -->|"expressed in"| RETINA
HCN1["HCN1"] -->|"expressed in"| RETINA
P62["P62"] -->|"expressed in"| RETINA
Complement_System["Complement System"] -->|"expressed in"| RETINA
ABCA4["ABCA4"] -->|"expressed in"| RETINA
PARK7["PARK7"] -->|"expressed in"| RETINA
MICROGLIA["MICROGLIA"] -->|"expressed in"| RETINA| Target | Relation | Type | Str |
|---|---|---|---|
| Alzheimer's Disease | biomarker_for | disease | 0.80 |
| RETINOPATHY | causes | disease | 0.65 |
| NEURONS | produces | cell_type | 0.65 |
| OBESITY | interacts_with | disease | 0.65 |
| VISUAL CORTEX | activates | brain_region | 0.65 |
| GABA | inhibits | phenotype | 0.65 |
| NEURONS | causes | cell_type | 0.65 |
| MITOCHONDRIAL DYSFUNCTION | inhibits | phenotype | 0.65 |
| GLAUCOMA | causes | disease | 0.65 |
| NEURODEGENERATION | interacts_with | phenotype | 0.65 |
| AMYLOID | targets | protein | 0.60 |
| TREGS | associated_with | cell_type | 0.50 |
| HDAC3 | associated_with | gene | 0.50 |
| GABA | associated_with | phenotype | 0.50 |
| ALS | associated_with | disease | 0.50 |
| AGING | associated_with | phenotype | 0.50 |
| MOG | associated_with | gene | 0.50 |
| CORTEX | associated_with | brain_region | 0.45 |
| TAU | associated_with | protein | 0.45 |
| AQP4 | associated_with | gene | 0.45 |
| NLRP3 | associated_with | gene | 0.45 |
| HK2 | associated_with | gene | 0.45 |
| VISUAL CORTEX | associated_with | brain_region | 0.45 |
| CSF | associated_with | phenotype | 0.45 |
| CGAS | associated_with | gene | 0.45 |
| STING | associated_with | gene | 0.45 |
| P38 | associated_with | gene | 0.45 |
| P2RX7 | associated_with | gene | 0.45 |
| T CELLS | implicated_in | cell_type | 0.35 |
| STROKE | activates | disease | 0.35 |
| RETINAL DEGENERATION | causes | disease | 0.35 |
| SPINAL CORD | activates | brain_region | 0.35 |
| Source | Relation | Type | Str |
|---|---|---|---|
| HCN1 | expressed_in | entity | 0.90 |
| HCN1 | expressed_in | gene | 0.90 |
| Amyloid Deposits | biomarker_for | biomarker | 0.90 |
| AMYLOID BETA | expressed_in | protein | 0.90 |
| TAU PROTEIN | expressed_in | protein | 0.90 |
| Reduced Blood Flow | associated_with | phenotype | 0.90 |
| P62 | expressed_in | protein | 0.90 |
| Mitochondrial Dysfunction | associated_with | process | 0.85 |
| Intestinal Bacteria | transports | compound | 0.85 |
| Vasculopathy | biomarker_for | phenotype | 0.85 |
| Dysregulated Proteins | expressed_in | biomarker | 0.80 |
| ABCA4 | expressed_in | gene | 0.75 |
| HDAC3 | regulates | gene | 0.65 |
| ALZHEIMER | activates | disease | 0.65 |
| GABA | regulates | phenotype | 0.65 |
| HDAC3 | protects_against | gene | 0.65 |
| INFLAMMATION | protects_against | phenotype | 0.65 |
| MITOPHAGY | stabilizes | phenotype | 0.60 |
| TREGS | targets | cell_type | 0.60 |
| PARK7 | expressed_in | gene | 0.60 |
| AQP4 | implicated_in | gene | 0.55 |
| NEURON | associated_with | cell_type | 0.50 |
| SYNAPTIC TRANSMISSION | associated_with | phenotype | 0.50 |
| DEMYELINATION | associated_with | phenotype | 0.50 |
| ASTROCYTES | associated_with | cell_type | 0.50 |
| OBESITY | associated_with | disease | 0.50 |
| MICROGLIA | expressed_in | cell_type | 0.50 |
| MICROGLIAL ACTIVATION | associated_with | phenotype | 0.50 |
| ALZHEIMER'S DISEASE | associated_with | disease | 0.50 |
| NLRP3 INFLAMMASOME | associated_with | pathway | 0.45 |
| MICROGLIA | associated_with | cell_type | 0.45 |
| MULTIPLE SCLEROSIS | associated_with | disease | 0.45 |
| NEURONS | associated_with | cell_type | 0.45 |
| APOPTOSIS | associated_with | phenotype | 0.45 |
| ALZHEIMER | associated_with | disease | 0.45 |
| AMYLOID | associated_with | protein | 0.45 |
| ISCHEMIA | associated_with | disease | 0.45 |
| DIABETES | associated_with | disease | 0.45 |
| GLAUCOMA | associated_with | disease | 0.45 |
| COMPLEMENT ACTIVATION | associated_with | phenotype | 0.45 |
| RETINOPATHY | associated_with | disease | 0.45 |
| MACULAR DEGENERATION | associated_with | disease | 0.45 |
| AUTOPHAGY | associated_with | phenotype | 0.45 |
| DEMENTIA | associated_with | disease | 0.45 |
| NEUROINFLAMMATION | associated_with | phenotype | 0.45 |
| ASTROCYTE | associated_with | cell_type | 0.45 |
| CALCIUM SIGNALING | associated_with | pathway | 0.45 |
| STING PATHWAY | associated_with | pathway | 0.45 |
| INFLAMMATION | associated_with | phenotype | 0.45 |
| STROKE | associated_with | disease | 0.45 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Retinal Vascular Microcirculation Rescue | 0.718 | neurodegeneration | Digital biomarkers and AI-driven early d |
| Transient OCT4/SOX2/KLF4/c-MYC Expression Reverses Epigeneti | 0.540 | neurodegeneration | epigenetic reprogramming aging neurons |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Proposed experiment from debate on Perivascular spaces and glymphatic | falsification | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $100,000 |
| Blood-Brain Barrier Aging and Neurodegeneration — From Leakage to Neur | validation | Neurodegeneration | 0.400 | 0.50 | cell_line | proposed | $130,000 |
| Prodromal Parkinson's Disease Biomarker Development — Early Detection | clinical | Parkinson's Disease | 0.400 | 0.50 | human | proposed | $6,550,000 |
| Vascular Contribution to Alzheimer's Disease — Beyond Amyloid | validation | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $2,280,000 |
| Vascular Contributions to Alzheimer Disease and Mixed Pathology | clinical | Alzheimer's Disease | 0.400 | 0.50 | human | proposed | $5,460,000 |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Pericyte-derived extracellular vesicles improve vascular barrier function in sep [PMID:39940043] | Zhang ZS, Yang A, Luo X, Zhou HN, Liu YY | Stem Cell Res Ther | 2025 | 1 |
| Irisin promotes fracture healing by improving osteogenesis and angiogenesis. [PMID:36196152] | Kan T, He Z, Du J, Xu M, Cui J, Han X, T | J Orthop Translat | 2022 | 1 |
| STING activation reprograms tumor vasculatures and synergizes with VEGFR2 blocka [PMID:31343989] | Yang H, Lee WS, Kong SJ, Kim CG, Kim JH, | J Clin Invest | 2019 | 1 |
| Astrocyte-Glioblastoma Stem Cell Interactions via Extracellular Vesicles Contrib [PMID:41712235] | Shirai Y, Tsuda M, Wang L, Oda Y, Sugizn | Pathology international | 2026 | 0 |
| Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-c [PMID:37941480] | ["De Coninck S", "De Smedt R", "Linterma | Haematologica | 2024 | 0 |
| The ten genes for breast (and ovarian) cancer susceptibility. [PMID:33692540] | William D Foulkes | Nature reviews. Clinical oncol | 2021 | 0 |
| Nasal and lip polyps: Pai syndrome. [PMID:31196564] | Cinthia Giselle Pérez; Sandra Carrera Fe | Acta otorrinolaringologica esp | 2021 | 0 |
| Observation of Magic Number Clusters from Thermal Dissociation Molecular Dynamic [PMID:32286071] | ["Zhang J", "Bogdanov B", "Parkins A", " | The journal of physical chemis | 2020 | 0 |
| Reciprocal associations between depression, anxiety and work-related injury. [PMID:31685530] | ["Gerasimaviciute V", "B\u00fcltmann U", | Injury prevention : journal of | 2020 | 0 |
| Crenolanib-Derived Probes Suitable for Cell- and Tissue-Based Protein Profiling [PMID:30942519] | ["Chang Y", "Zhu D", "Guo H", "Yin X", " | Chembiochem : a European journ | 2019 | 0 |
| Layer-specific integration of locomotion and sensory information in mouse barrel [PMID:31197148] | ["Ayaz A", "St\u00e4uble A", "Hamada M", | Nature communications | 2019 | 0 |
| Bright spots physical activity investments that work: Youth-Physical Activity To [PMID:30315116] | Sarahjane Belton; Wesley O'Brien; Jamie | British journal of sports medi | 2018 | 0 |
| Somatic APP gene recombination in Alzheimer's disease and normal neurons. [PMID:30464338] | ["Lee M", "Siddoway B", "Kaeser G", "Seg | Nature | 2018 | 0 |
| Tyrosine Kinase Inhibitors Regulate OPG through Inhibition of PDGFRβ. [PMID:27737004] | ["O'Sullivan S", "Tay M", "Lin J", "Bava | PloS one | 2016 | 0 |
| Experiences With Aggressive Cardiac Rehabilitation in Pediatric Patients Receivi [PMID:27829640] | ["Amao R", "Imamura T", "Sawada Y", "End | International heart journal | 2016 | 0 |
| Platelet-derived growth factor BB and DD and angiopoietin1 are altered in follic [PMID:24889290] | Scotti L, Parborell F, Irusta G, De Zuñi | Molecular reproduction and dev | 2014 | 0 |
| PKM2 enters the morpheein academy. [PMID:22405271] | ["Semenova G", "Chernoff J"] | Molecular cell | 2012 | 0 |
| Recombinant angiopoietin-1 restores higher-order architecture of growing blood v [PMID:12464667] | Uemura A, Ogawa M, Hirashima M, Fujiwara | The Journal of clinical invest | 2002 | 0 |
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning RETINA in their description or question text
No additional research found